GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (NAS:BWAY) » Definitions » Cyclically Adjusted PB Ratio

BrainsWay (BrainsWay) Cyclically Adjusted PB Ratio : 2.83 (As of Jun. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is BrainsWay Cyclically Adjusted PB Ratio?

As of today (2024-06-11), BrainsWay's current share price is $6.66. BrainsWay's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.35. BrainsWay's Cyclically Adjusted PB Ratio for today is 2.83.

The historical rank and industry rank for BrainsWay's Cyclically Adjusted PB Ratio or its related term are showing as below:

BWAY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.51   Med: 2.34   Max: 2.93
Current: 2.76

During the past years, BrainsWay's highest Cyclically Adjusted PB Ratio was 2.93. The lowest was 1.51. And the median was 2.34.

BWAY's Cyclically Adjusted PB Ratio is ranked worse than
62.66% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.065 vs BWAY: 2.76

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BrainsWay's adjusted book value per share data for the three months ended in Mar. 2024 was $2.524. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.35 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BrainsWay Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BrainsWay's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Cyclically Adjusted PB Ratio Chart

BrainsWay Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.55

BrainsWay Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.73 2.55 2.25

Competitive Comparison of BrainsWay's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, BrainsWay's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrainsWay's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BrainsWay's Cyclically Adjusted PB Ratio falls into.



BrainsWay Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BrainsWay's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.66/2.35
=2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrainsWay's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BrainsWay's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.524/131.7762*131.7762
=2.524

Current CPI (Mar. 2024) = 131.7762.

BrainsWay Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 2.093 99.070 2.784
201503 2.050 99.621 2.712
201506 1.862 100.684 2.437
201509 1.837 100.392 2.411
201512 1.780 99.792 2.350
201603 1.728 100.470 2.266
201606 1.640 101.688 2.125
201609 1.552 101.861 2.008
201612 1.398 101.863 1.809
201703 1.160 102.862 1.486
201706 1.002 103.349 1.278
201709 0.816 104.136 1.033
201712 1.529 104.011 1.937
201803 1.434 105.290 1.795
201806 1.222 106.317 1.515
201809 1.064 106.507 1.316
201812 0.836 105.998 1.039
201903 0.500 107.251 0.614
201906 2.572 108.070 3.136
201909 2.361 108.329 2.872
201912 2.178 108.420 2.647
202003 1.895 108.902 2.293
202006 1.856 108.767 2.249
202009 1.771 109.815 2.125
202012 1.765 109.897 2.116
202103 3.728 111.754 4.396
202106 3.627 114.631 4.169
202109 3.541 115.734 4.032
202112 3.484 117.630 3.903
202203 3.380 121.301 3.672
202206 3.252 125.017 3.428
202209 2.961 125.227 3.116
202212 2.747 125.222 2.891
202303 2.595 127.348 2.685
202306 2.494 128.729 2.553
202309 2.483 129.860 2.520
202312 2.502 129.419 2.548
202403 2.524 131.776 2.524

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BrainsWay  (NAS:BWAY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BrainsWay Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BrainsWay's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BrainsWay (BrainsWay) Business Description

Traded in Other Exchanges
Address
19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.